Becton, Dickinson and Company

NYSE:BDX

Medical - Instruments & Supplies

Healthcare
$216.08 +1.67%

+$2.36 today

Market cap
$58.86B
Beta
0.28
P/E (TTM)
35.5
EPS (TTM)
$4.06
Dividend yield
2.60%
52W Low $127.59High $187.35

Volume 1.32M

Average 2.76M

BDX Pre-Tax Margin

Income before tax as a percentage of revenue.

Becton, Dickinson and CompanyNYSE: BDX

Pre-Tax Margin · Q4 FY2026 · quarter ended Sep 2026

Pre-tax margin widens to 17.1%

Pre-tax margin was 17.1% in Q4 FY2026, up 8.4 pp from a year earlier. On a trailing-twelve-month basis it was 9.8%, up 1.2 pp year over year. Over 3 fiscal years it widened by 0.7 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
17.1%+6.0 pp QoQ
Last fiscal yearSep 2026
9.3%+0.7 pp YoY
LTMSep 2026
9.8%+1.2 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+8.4 pp——
1 year+0.7 pp——
3 years+0.7 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2026
9.3%
Year-over-year change
+0.7pp

Pre-Tax Margin vs competitors

How BDX compares with its peers on the latest reported figures

  • BDX's LTM Sep 2026 pre-tax margin of 9.8% is the 7th highest of the 11 companies compared; the peer median is 13.4%.
  • Its year-over-year change of +1.2 pp is the 5th highest of 11, against a peer median of +0.7 pp.
  • Over three fiscal years its change of +0.7 pp compares with a peer median of -0.3 pp.
BDX Competitors Peer median
Pre-Tax Margin for BDX and competitors
Company Period LTM level YoY 3-year change
WSTWest Pharmaceutical Services, Inc.LTM Jun 202621.0% +0.4 pp-4.3 pp
SOLVSolventum CorporationLTM Jun 202620.4% +16.6 pp-0.2 pp
MDTMedtronic plcLTM Jul 202617.6% +1.0 pp-0.3 pp
EMBCEmbecta Corp.LTM Mar 202616.3% +11.2 pp-10.1 pp
ABTAbbott LaboratoriesLTM Sep 202613.6% -5.0 pp+0.1 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202613.1% +2.8 pp+4.1 pp
BDXBecton, Dickinson and CompanyLTM Sep 20269.8% +1.2 pp+0.7 pp
ICUIICU Medical, Inc.LTM Jun 2026-0.2% -0.8 pp+5.2 pp
BAXBaxter International Inc.LTM Jun 2026-4.2% -1.3 pp+27.8 pp
BLFSBioLife Solutions, Inc.LTM Mar 2026-10.4% +1.8 pp-6.2 pp
TFXTeleflex IncorporatedLTM Jun 2026-15.8% -23.9 pp-14.7 pp
Peer median (excluding BDX) 13.4%+0.7 pp-0.3 pp

Competitors are the stored peer set for BDX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Revenue18.87B19.37B20.18B21.84B19.46B
Cost of Revenue10.39B11.2B11.05B11.92B10.24B
Gross Profit8.48B8.17B9.13B9.92B9.21B
Gross Margin44.9%42.2%45.2%45.4%47.4%
Research & Development1.26B1.24B1.19B1.26B988M
Selling, General & Admin4.71B4.72B4.86B5.28B4.97B
Operating Expenses6.2B6.06B6.73B7.35B6.96B
Depreciation & Amortization2.23B2.29B2.29B2.46B2.24B
EBITDA4.41B4.4B4.82B4.96B4.61B
EBITDA Margin23.4%22.7%23.9%22.7%23.7%
Operating Income2.28B2.11B2.4B2.58B2.26B
Operating Margin12.1%10.9%11.9%11.8%11.6%
Interest Income16M49M163M38M27M
Interest Expense398M452M528M613M564M
Other Income / Expenses(499M)(449M)(392M)(696M)(451M)
Income Before Tax1.78B1.66B2.01B1.88B1.81B
Pre-Tax Margin9.4%8.6%9.9%8.6%9.3%
Income Tax Expense148M132M300M204M388M
Net Income1.78B1.48B1.71B1.68B1.15B
Net Margin9.4%7.7%8.4%7.7%5.9%
EPS (Basic)5.934.975.885.844.11
EPS (Diluted)5.884.945.865.834.09
Weighted Avg Shares285.01M286.28M289.76M286.61M278.49M
Weighted Avg Shares (Diluted)287.36M288.39M291.01M287.12M279.94M

Becton, Dickinson and Company

NYSE:BDX

Intrinsic Alpha fair value

Locked

Current Price

$216.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.